Overview
The Ministry of Health and Family Welfare (MoHFW) has issued an amendment to the Drugs Rules, 1945. The amendment removes the word “Syrup” from Entry 13 of Schedule K, thereby ending the long‑standing exemption that allowed the sale of cough syrup in villages with a population below 1,000 without a pharmacy licence.
Key Developments
- Gazette Notification G.S.R. 927 (E) dated 29 December 2025, published on 30 December 2025, officially amends the Rules.
- The word “Syrup” is deleted from Schedule K, Serial No. 13, Entry 7 under the heading “Class of Drugs”.
- Sale of cough syrups in small villages must now occur only through a licensed pharmacy as per the Drugs and Cosmetics Act, 1940 and its Rules.
- Manufacturers, distributors and retailers are directed to comply with the new licensing requirements.
Important Facts
The amendment targets a specific exemption that previously applied only to villages with fewer than 1,000 residents. By removing the exemption, the government aims to tighten regulatory oversight of liquid drug formulations, which are prone to misuse. The e‑Gazette containing the full text is available at https://egazette.gov.in/WriteReadData/2026/273467.pdf.
Relevance for UPSC Aspirants
Understanding this change is important for several reasons:
- Public Health Governance: It reflects how the Union government uses statutory amendments to address emerging health‑safety concerns.
- Regulatory Framework: The move underscores the role of the Drugs and Cosmetics Act and its Rules in controlling the pharmaceutical market.
- Policy Implementation: The amendment illustrates the procedural use of Gazette Notification to give legal effect to policy decisions.
- Administrative Law: It showcases the interaction between central ministries and statutory provisions, a frequent topic in GS 2 (Polity) and GS 3 (Economy).
Way Forward
Stakeholders must update their compliance manuals and ensure that all outlets dispensing cough syrups obtain the requisite pharmacy licence. State health departments should coordinate with the MoHFW to monitor implementation, especially in remote areas where informal sales were common. For aspirants, tracking such regulatory tweaks helps in answering questions on health policy, drug regulation, and the use of statutory instruments in governance.